Tactical Opportunit Blackstone Buys 2,500,000 Shares of Sema4 Holdings Corp. (NASDAQ:SMFR) Stock

Sema4 Holdings Corp. (NASDAQ:SMFR – Get Rating) major shareholder Tactical Opportunit Blackstone bought 2,500,000 shares of Sema4 stock in a transaction dated Friday, April 29th. The shares were acquired at an average price of $4.00 per share, with a total value of $10,000,000.00. Following the completion of the purchase, the insider now directly owns 26,839,187 shares in the company, valued at approximately $107,356,748. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this link. Large shareholders that own more than 10% of a company’s stock are required to disclose their sales and purchases with the SEC.

SMFR opened at $2.15 on Wednesday. The business has a fifty day simple moving average of $2.80 and a 200 day simple moving average of $4.43. Sema4 Holdings Corp. has a 1 year low of $2.10 and a 1 year high of $15.21. The company has a debt-to-equity ratio of 0.08, a quick ratio of 4.44 and a current ratio of 4.77.

Sema4 (NASDAQ:SMFR – Get Rating) last released its quarterly earnings results on Monday, March 14th. The company reported ($0.17) earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.22) by $0.05. The firm had revenue of $57.80 million during the quarter, compared to the consensus estimate of $50.90 million. As a group, sell-side analysts anticipate that Sema4 Holdings Corp. will post -0.8 EPS for the current year.

SMFR has been the subject of several research analyst reports. BTIG Research reiterated a “buy” rating and set a $8.00 target price on shares of Sema4 in a research note on Friday, January 21st. Zacks Investment Research downgraded Sema4 from a “hold” rating to a “sell” rating in a research note on Thursday, April 28th. One investment analyst has rated the stock with a sell rating and four have issued a buy rating to the stock. According to data from MarketBeat.com, Sema4 presently has an average rating of “Buy” and an average target price of $11.50.

Hedge funds and other institutional investors have recently made changes to their positions in the business. Royal Bank of Canada acquired a new position in Sema4 in the 3rd quarter valued at $36,000. Citigroup Inc. acquired a new position in Sema4 in the 3rd quarter valued at $79,000. Victory Capital Management Inc. acquired a new position in Sema4 in the 3rd quarter valued at $88,000. CIBC Asset Management Inc acquired a new position in Sema4 in the 4th quarter valued at $56,000. Finally, Tudor Investment Corp Et Al acquired a new position in Sema4 in the 3rd quarter valued at $106,000.

Sema4 Company Profile (Get Rating)

Sema4 Holdings Corp., doing business as Sema4, operates as a health information company that enhances diagnosis, treatment, and prevention of disease through data. The company provides Centrellis, an AI-driven health intelligence platform that delivers comprehensive insights to biopharma to accelerate the drug discovery, development, and commercialization life-cycle, as well as analytics for actionable insights, pre-clinical and clinical trial support, and advanced sequencing services.

Featured Stories